Trial Profile
A study investigating the immunogenicity of Twinrix (Hepatitis A-hepatitis B vaccine; GlaxoSmithKline) in volunteers susceptible to hepatitis B during an outbreak
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2023
Price :
$35
*
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 30 Dec 2015 New trial record